Gesamter Bestand

Auflistung Nach Schlagwort "time to treatment"

Anzeige der Dokumente 1-20 von 25

    • Angiotensin receptor-neprilysin inhibition in patients with acute decompensated heart failure: an expert consensus position paper 

      Ntalianis A., Chrysohoou C., Giannakoulas G., Giamouzis G., Karavidas A., Naka A., Papadopoulos C.H., Patsilinakos S., Parissis J., Tziakas D., Kanakakis J. (2022)
      The short-term mortality and rehospitalization rates after admission for acute heart failure (AHF) remain high, despite the high level of adherence to contemporary practice guidelines. Observational data from non-randomized ...

    • Autism spectrum disorder, anxiety and severe depression in a male patient with deletion and duplication in the 21q22.3 region: A case report 

      Orru S., Papoulidis I., Siomou E., Papadimitriou D.T., Sotiriou S., Nikolaidis P., Eleftheriades M., Papanikolaou E., Thomaidis L., Manolakos E. (2019)
      In this report, a patient carrying a 650 kb deletion and a 759 kb duplication of chromosomal 21q22.3 region was described. Facial dysmorphic features, hypotonia, short stature, learning impairment, autism spectrum disorder, ...

    • Characteristics and Outcomes in Patients with COVID-19 and Acute Ischemic Stroke: The Global COVID-19 Stroke Registry 

      Ntaios G., Michel P., Georgiopoulos G., Guo Y., Li W., Xiong J., Calleja P., Ostos F., González-Ortega G., Fuentes B., Alonso De Leciñana M., Díez-Tejedor E., García-Madrona S., Masjuan J., Defelipe A., Turc G., Gonçalves B., Domigo V., Dan G.-A., Vezeteu R., Christensen H., Christensen L.M., Meden P., Hajdarevic L., Rodriguez-Lopez A., Díaz-Otero F., García-Pastor A., Gil-Nuñez A., Maslias E., Strambo D., Werring D.J., Chandratheva A., Benjamin L., Simister R., Perry R., Beyrouti R., Jabbour P., Sweid A., Tjoumakaris S., Cuadrado-Godia E., Campello A.R., Roquer J., Moreira T., Mazya M.V., Bandini F., Matz K., Iversen H.K., González-Duarte A., Tiu C., Ferrari J., Vosko M.R., Salzer H.J.F., Lamprecht B., Dünser M.W., Cereda C.W., Quintero Á.B.C., Korompoki E., Soriano-Navarro E., Soto-Ramírez L.E., Castañeda-Méndez P.F., Bay-Sansores D., Arauz A., Cano-Nigenda V., Kristoffersen E.S., Tiainen M., Strbian D., Putaala J., Lip G.Y.H. (2020)
      Recent case-series of small size implied a pathophysiological association between coronavirus disease 2019 (COVID-19) and severe large-vessel acute ischemic stroke. Given that severe strokes are typically associated with ...

    • The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 165 Patients with Tubercular Anterior Uveitis 

      Agrawal R., MD FCRS, Betzler B., MBBS, Testi I., MD, Mahajan S., MBBS, Agarwal A., MS, Gunasekeran D.V., MD, Raje D., PhD, Aggarwal K., MS, Murthy S.I., DNB, Westcott M., FRCSOphth, Chee S.-P., FRCSEd, Mccluskey P., MD, Ho S.L., FRCSGlasg, Teoh S., FRCSEd, Cimino L., MD, Biswas J., MS, Narain S., MD, Agarwal M., MS, Mahendradas P., DNB, Khairallah M., MD, Jones N., FRCSOphth, Tugal-Tutkun I., MD, Babu K., DNB, Basu S., MS, Carreño E., MD, Lee R., PhD, Al-Dhibi H., MD, Bodaghi B., MD, Invernizzi A., MD, Goldstein D.A., MD, Herbort C.P., MD, Barisani-Asenbauer T., PhD, González-López J.J., PhD, Androudi S., MD, Bansal R., MS, Moharana B., MS, Esposti S., MD, Tasiopoulou A., MD, Nadarajah S., MD, Agarwal M., DNB, Abraham S., MD, Vala R., MD, Singh R., MS, Sharma A., MD, Sharma K., PhD, Zierhut M., PhD, Kon O.M., MRCP, Cunningham E.T., PhD, Kempen J.H., PhD, Nguyen Q.D., PhD, Pavesio C., FRCSOphth, Gupta V., MS (2020)
      Purpose: The Collaborative Ocular Tuberculosis Study (COTS) Group sought to address the diagnostic uncertainty through retrospective cohort analysis of treatment regimens and therapeutic outcomes for patients with tubercular ...

    • Consensus statement from the international consensus meeting on post-traumatic cranioplasty 

      Iaccarino C., Kolias A., Adelson P.D., Rubiano A.M., Viaroli E., Buki A., Cinalli G., Fountas K., Khan T., Signoretti S., Waran V., Adeleye A.O., Amorim R., Bertuccio A., Cama A., Chesnut R.M., De Bonis P., Estraneo A., Figaji A., Florian S.I., Formisano R., Frassanito P., Gatos C., Germanò A., Giussani C., Hossain I., Kasprzak P., La Porta F., Lindner D., Maas A.I.R., Paiva W., Palma P., Park K.B., Peretta P., Pompucci A., Posti J., Sengupta S.K., Sinha A., Sinha V., Stefini R., Talamonti G., Tasiou A., Zona G., Zucchelli M., Hutchinson P.J., Servadei F. (2021)
      Background: Due to the lack of high-quality evidence which has hindered the development of evidence-based guidelines, there is a need to provide general guidance on cranioplasty (CP) following traumatic brain injury (TBI), ...

    • Early corticosteroid initiation delays viral RNA clearance in respiratory secretions of COVID-19 patients 

      Pantazopoulos I., Mavrovounis G., Kyritsis A., Perlepe G., Miziou A., Gourgoulianis K. (2021)
      [No abstract available]

    • The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes 

      Diamantopoulos P.T., Symeonidis A., Pappa V., Kotsianidis I., Galanopoulos A., Pontikoglou C., Anagnostopoulos A., Vassilopoulos G., Zikos P., Hatzimichael E., Papaioannou M., Megalakaki A., Repousis P., Kotsopoulou M., Dimou M., Solomou E., Dryllis G., Tsokanas D., Papoutselis M.-K., Papageorgiou S., Kyrtshonis M.-C., Kourakli A., Papadaki H., Panayiotidis P., Viniou N.-A. (2021)
      The regimen of 5-azacytidine for patients with myelodysplastic syndrome (MDS) has remained unchanged since its first approval. Although several modifications have since been made and delays and dose reductions are common ...

    • Effect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome after Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial 

      Woodhouse L., Scutt P., Krishnan K., Berge E., Gommans J., Ntaios G., Wardlaw J., Sprigg N., Bath P.M. (2015)
      Background and Purpose-Nitric oxide donors are candidate treatments for acute stroke, potentially through hemodynamic, reperfusion, and neuroprotectant effects, especially if given early. Although the large Efficacy of ...

    • Endovascular Thrombectomy in Acute Ischemic Stroke 

      Papanagiotou P., Ntaios G. (2018)
      Despite several effective strategies of stroke prevention, the stroke epidemic still constitutes the leading cause of permanent disability. The recent series of well-designed, convincingly-positive randomized controlled ...

    • Exercise stress testing: Time to restart in nuclear cardiology? 

      Angelidis G., Valotassiou V., Psimadas D., Georgoulias P. (2020)
      [No abstract available]

    • Heart rate variability dynamics during treatment for exertional heat strain when immediate response is not possible 

      Flouris A.D., Friesen B.J., Herry C.L., Seely A.J.E., Notley S.R., Kenny G.P. (2019)
      New Findings: What is the central question of this study? Does a delay in cold water immersion treatment affect the cardiac autonomic control of exertionally heat-strained individuals? What is the main finding and its ...

    • Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 

      Paciaroni M., Bandini F., Agnelli G., Tsivgoulis G., Yaghi S., Furie K.L., Tadi P., Becattini C., Zedde M., Abdul-Rahim A.H., Lees K.R., Alberti A., Venti M., Acciarresi M., D’Amore C., Mosconi M.G., Cimini L.A., Altavilla R., Volpi G., Bovi P., Carletti M., Rigatelli A., Cappellari M., Putaala J., Tomppo L., Tatlisumak T., Marcheselli S., Pezzini A., Poli L., Padovani A., Masotti L., Vannucchi V., Sohn S.-I., Lorenzini G., Tassi R., Guideri F., Acampa M., Martini G., Ntaios G., Athanasakis G., Makaritsis K., Karagkiozi E., Vadikolias K., Liantinioti C., Chondrogianni M., Mumoli N., Consoli D., Galati F., Sacco S., Carolei A., Tiseo C., Corea F., Ageno W., Bellesini M., Colombo G., Silvestrelli G., Ciccone A., Lanari A., Scoditti U., Denti L., Mancuso M., Maccarrone M., Ulivi L., Orlandi G., Giannini N., Gialdini G., Tassinari T., De Lodovici M.L., Bono G., Rueckert C., Baldi A., D'Anna S., Toni D., Letteri F., Giuntini M., Lotti E.M., Flomin Y., Pieroni A., Kargiotis O., Karapanayiotides T., Monaco S., Baronello M.M., Csiba L., Szabó L., Chiti A., Giorli E., Del Sette M., Imberti D., Zabzuni D., Doronin B., Volodina V., Michel P., Vanacker P., Barlinn K., Pallesen L.-P., Barlinn J., Deleu D., Melikyan G., Ibrahim F., Akhtar N., Gourbali V., Caso V. (2018)
      Background—In patients with acute ischemic stroke and atrial fibrillation, early anticoagulation prevents ischemic recurrence but with the risk of hemorrhagic transformation (HT). The aims of this study were to evaluate ...

    • Interrupted versus uninterrupted anticoagulation therapy for catheter ablation in adults with arrhythmias 

      Bawazeer G.A., Alkofide H.A., Alsharafi A.A., Babakr N.O., Altorkistani A.M., Kashour T.S., Miligkos M., AlFaleh K.M., Al-Ansary L.A. (2021)
      Background: The management of anticoagulation therapy around the time of catheter ablation (CA) procedure for adults with arrhythmia is critical and yet is variable in clinical practice. The ideal approach for safe and ...

    • Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration 

      Altersberger V.L., Rusche N., Martinez-Majander N., Hametner C., Scheitz J.F., Henon H., Dell'acqua M.L., Strambo D., Stolp J., Heldner M.R., Grisendi I., Jovanovic D.R., Bejot Y., Pezzini A., Leker R.R., Kägi G., Wegener S., Cereda C.W., Lindgren E., Ntaios G., Piot I., Polymeris A.A., Lyrer P.A., Räty S., Sibolt G., Tiainen M., Heyse M., Erdur H., Kaaouana O., Padjen V., Zedde M., Arnold M., Nederkoorn P.J., Michel P., Bigliardi G., Zini A., Cordonnier C., Nolte C.H., Ringleb P.A., Curtze S., Engelter S.T., Gensicke H., for the Thrombolysis in Stroke Patients (TRISP) Collaborators (2022)
      Background: The probability to receive intravenous thrombolysis (IVT) for treatment of acute ischemic stroke declines with increasing age and is consequently the lowest in very elderly patients. Safety concerns likely ...

    • Investigating the optimal time for intrauterine human chorionic gonadotropin infusion in order to improve IVF outcome: A systematic review and meta-analysis 

      Simopoulou M., Sfakianoudis K., Maziotis E., Tsioulou P., Giannelou P., Grigoriadis S., Pantou A., Anifandis G., Christopoulos P., Pantos K., Koutsilieris M. (2019)
      Background/Aim: Studies on the impact of intrauterine human Chorionic Gonadotropin (hCG) administration in order to improve the In Vitro Fertilization (IVF) outcome have yielded conflicting results. The aim of the present ...

    • Maintenance of Acute Stroke Care Service during the COVID-19 Pandemic Lockdown 

      Altersberger V.L., Stolze L.J., Heldner M.R., Henon H., Martinez-Majander N., Hametner C., Nordanstig A., Zini A., Nannoni S., Gonçalves B., Nolte C.H., Baumgartner P., Kastrup A., Papanagiotou P., Kägi G., Leker R.R., Zedde M., Padovani A., Pezzini A., Padjen V., Cereda C.W., Ntaios G., Bonati L.H., Rinkel L.A., Fischer U., Scheitz J.F., Wegener S., Turc G., Michel P., Gentile M., Rentzos A., Ringleb P.A., Curtze S., Cordonnier C., Arnold M., Nederkoorn P.J., Engelter S.T., Gensicke H., TRISP Collaborators (2021)
      BACKGROUND AND PURPOSE: Timely reperfusion is an important goal in treatment of eligible patients with acute ischemic stroke. However, during the coronavirus disease 2019 (COVID-19) pandemic, prehospital and in-hospital ...

    • Management of scaphoid nonunions with vascularized bone grafts from the distal radius: mid- to long-term follow-up 

      Malizos K.N., Dailiana Z., Varitimidis S., Koutalos A. (2017)
      Scaphoid nonunion represents a challenging problem that leads to disability if neglected. Vascularized bone grafts are proposed to augment the local biology and increase the likelihood of union but long-term outcomes are ...

    • A meta-analysis of liver-first versus classical strategy for synchronous colorectal liver metastases 

      Magouliotis D.E., Tzovaras G., Diamantis A., Tasiopoulou V.S., Zacharoulis D. (2020)
      Background: This study aimed to compare the perioperative outcomes of liver-first (LFS) and classical (CS) strategy for the management of synchronous colorectal liver metastases (sCRLM). Method: A literature search was ...

    • Musculoskeletal infection in orthopaedic trauma: Assessment of the 2018 international consensus meeting on musculoskeletal infection 

      Obremskey W.T., Metsemakers W.-J., Schlatterer D.R., Tetsworth K., Egol K., Kates S., McNally M., Gibbons J., Kenny P., Stangl P., Patzakis M.J., Ferreira N., Tornetta P., III, Suda A.J., O'Hara N., Salles M.J.C., Bhashyam A.R., Morgenstern M., Manrique J., Malizos K.N., Giannoudis P., Nana A., Egol K.A., Kleftouris G., Reyes F., Klement M.R., Bautista M., Linke P., Citak M., Abdelaziz H., Ecker N.U., Suero E., Caba P., Marais L., Haasper C., Papakostidis C., Natoli R.M., Aldahamsheh O., Abuodeh Y., Quinnan S., Suarez C., Conway J.D., Sánchez Correa C.A., Leal J.A., Zalavras C., Komnos G., Shope A.J., Saxena A., Fram B., Akesson P., Haggard W.O., Vahedi H., Athanaselis E., Pesantez R., Lowenberg D.W., Gleason B., Hendershot E.F., Amaris G., Kates S.L., Chang G., Archdeacon M.T., Pinzón A., Shetty R.P., Chan J., McNally M.A., Shaffer A., Schlatterer D.R., Harris M., Matsushita K., Kvederas G., Garcia M.F., Swiontkowski M.F., Kallel S., Gutierrez V., Alt V., O'Toole R.V., Watson J.T., ICM Orthopaedic Trauma Work Group (2020)
      Fracture-related infections (FRIs) are among the most common complications following fracture fixation, and they have a huge economic and functional impact on patients. Because consensus guidelines with respect to prevention, ...

    • Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis 

      Weismüller T.J., Strassburg C.P., Trivedi P.J., Hirschfield G.M., Trivedi P.J., Bergquist A., Said K., Imam M., Lazaridis K.N., Juran B.D., Cheung A., Lindor K.D., Weismüller T.J., Lenzen H., Manns M.P., Ponsioen C.Y., Beuers U., Holm K., Naess S., Karlsen T.H., Schrumpf E., Boberg K.M., Gotthardt D., Rupp C., Färkkilä M.A., Jokelainen K., Marschall H.-U., Benito de Valle M., Thorburn D., Saffioti F., Weersma R.K., Fevery J., Mueller T., Chazouillères O., Schulze K., Schramm C., Almer S., Pereira S.P., Levy C., Mason A., Bowlus C.L., Floreani A., Halilbasic E., Trauner M., Yimam K.K., Milkiewicz P., Milkiewicz P., Huynh D.K., Pares A., Manser C.N., Dalekos G.N., Eksteen B., Invernizzi P., Berg C.P., Kirchner G.I., Sarrazin C., Zimmer V., Fabris L., Braun F., Marzioni M., Schramm C., Chapman R.W., Chapman R.W., Lindor K.D., Imam M., Lindor K.D., Naess S., Karlsen T.H., Schrumpf E., Boberg K.M., Hansen B.E., Hansen B.E., Hansen B.E., on behalf of the, International PSC Study Group (2017)
      Background & Aims Primary sclerosing cholangitis (PSC) is an orphan hepatobiliary disorder associated with inflammatory bowel disease (IBD). We aimed to estimate the risk of disease progression based on distinct clinical ...